Trial intelligence / Profile preview

GHK-Cu Gel for Acute Wound Healing (CuHeal)

NCT07437586Phase 2Recruiting

Sponsor
Hudson Biotech
Start
Feb 2026
Primary completion
Feb 2027
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of GHK-Cu in Acute cutaneous wound, sponsored by Hudson Biotech. Started Feb 2026; status: recruiting.

02

Drugs

GHK-Cu
03

Conditions

Acute cutaneous wound

Beyond the preview

Go deeper on NCT07437586.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07437586.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call